Article

Relationship between therapeutic activity and preferential targeting of toxic soluble…

medRxiv · 2024 · Kaplan, J. M.; Gibbs, E.; Coutts, J.; Zhao, B.; Mackenzie, I.; Cashman, N. R.

Key facts

Title Relationship between therapeutic activity and preferential targeting of toxic soluble aggregates by amyloid-beta-directed antibodies
First author Kaplan, J. M.; Gibbs, E.; Coutts, J.; Zhao, B.; Mackenzie, I.; Cashman, N. R.
Journal medRxiv
Published Jan 1, 2024
DOI 10.1101/2024.04.20.590412
Devices mentioned K013373, K032311, K050423, K221932, K810863, K982382
Product codes mentioned CEK, DBM, DEW, GIA, CEM, CFN, CHL, KPS

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature